Interview: I’ve Got Hope Back in my Life
The Mary Tyler Moore Vision Initiative has a lofty goal: To halt and reverse vision loss from diabetes. Here’s one woman’s hope for a clearer future.
Moonshot Reimagined: Our Vision to Halt and Reverse Vision Loss
Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in honor of Mary Tyler Moore.
100, 100: Ending Diabetic Eye Disease, Forever
Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of blindness by 95%.
Two Studies Shed Light on Diabetic Kidney Disease
Two recent publications shed light on which people with type 1 diabetes will develop end-stage kidney disease, a complication of diabetes.
50+ Years with Type 1: An Interview with Dr. George King
I got the privilege of interviewing George King, M.D., whose research is on diabetes complications. Breakthrough T1D has funded him since he was early in his career.
At 37, I’m Fighting to Save my Eyesight
At the age of 37, I’m fighting to save my eyesight, a complication of type 1. People are also at risk of developing kidney, heart, and nerve diseases.
Keeping Your Kidneys Healthier, For Longer
Normally, the kidneys filter waste and extra water out of your blood to make urine. When your kidneys are damaged, they can’t filter blood like they should.
Breakthrough T1D Launches Center of Excellence at the University of Michigan
Breakthrough T1D today launched a Center of Excellence at the University of Michigan, to expand the University’s already stellar Elizabeth Weiser Caswell Diabetes Institute to tackle some of the most critical challenges in diabetes research. The goal: To yield safer day-to-day management and improved health for people with T1D by developing a comprehensive understanding of T1D metabolism.
Zucara Faces “Valley of Death,” and Comes Out Triumphant
Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for it, there are no preventive therapies. Zucara Therapeutics, however, may have an answer. It is developing a once-daily therapy that restores glucagon. Adding glucagon raises blood-sugar levels, preventing hypoglycemia and the symptoms that […]
Strengthening Type 1 Diabetes Science by Building Careers
Sometimes, the funding that Breakthrough T1D can provide for researchers is exactly the invitation they need to get into the field of type 1 diabetes (T1D) research. Other times, sustained grants are the critical boost that someone with more experience needs in order to branch out and establish his or her own lab. Creating and […]
